Also, cell proliferation was inhibited, as evident by the low expression, at almost 50% compared to the control group of PCNA (proliferating cell nuclear antigen) and Myc-oncogene (a key regulator of tumor microenvironment) in the treatment group [62]. This evidence concerns the gene MYC and neoplasm.